These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 15489399

  • 21. Levodopa can worsen tremor associated with dystonia.
    Hensman DJ, Bain PG.
    Mov Disord; 2006 Oct; 21(10):1778-80. PubMed ID: 16856131
    [Abstract] [Full Text] [Related]

  • 22. Hydrocephalic parkinsonism due to Paget's disease of bone: dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy.
    Ikeda K, Kinoshita M, Aoki K, Tomatsuri A.
    Mov Disord; 1997 Mar; 12(2):241-2. PubMed ID: 9087985
    [No Abstract] [Full Text] [Related]

  • 23. Parkinsonism following anterior choroidal artery stroke.
    Sibon I, Guyot M, Allard M, Tison F.
    Eur J Neurol; 2004 Apr; 11(4):283-4. PubMed ID: 15061831
    [No Abstract] [Full Text] [Related]

  • 24. Antimicrobial surveillance in idiopathic parkinsonism: indication-specific improvement in hypokinesia following Helicobacter pylori eradication and non-specific effect of antimicrobials for other indications in worsening rigidity.
    Dobbs SM, Charlett A, Dobbs RJ, Weller C, Iguodala O, Smee C, Lawson AJ, Taylor D, Bjarnason I.
    Helicobacter; 2013 Jun; 18(3):187-96. PubMed ID: 23336966
    [Abstract] [Full Text] [Related]

  • 25. Endoscopic third ventriculotomy improves parkinsonism following a ventriculo-peritoneal shunt in a patient with non-communicating hydrocephalus secondary to idiopathic aqueduct stenosis.
    Hashizume A, Watanabe H, Matsuo K, Katsuno M, Tanaka F, Nagatani T, Sobue G.
    J Neurol Sci; 2011 Oct 15; 309(1-2):148-50. PubMed ID: 21839479
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Levodopa-responsive rubral (Holmes') tremor.
    Vélez M, Cosentino C, Torres L.
    Mov Disord; 2002 Jul 15; 17(4):741-2. PubMed ID: 12210864
    [No Abstract] [Full Text] [Related]

  • 29. Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
    Lang AE.
    Mov Disord; 1995 Jul 15; 10(4):489-95. PubMed ID: 7565831
    [Abstract] [Full Text] [Related]

  • 30. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A, Schwarz J, Oertel WH, Pogarell O, Leenders KL.
    Mov Disord; 1997 Jan 15; 12(1):33-8. PubMed ID: 8990051
    [Abstract] [Full Text] [Related]

  • 31. Compensatory striatal-cerebellar connectivity in mild-moderate Parkinson's disease.
    Simioni AC, Dagher A, Fellows LK.
    Neuroimage Clin; 2016 Jan 15; 10():54-62. PubMed ID: 26702396
    [Abstract] [Full Text] [Related]

  • 32. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
    Riverol M, Ordóñez C, Collantes M, DiCaudo C, Peñuelas I, Arbizu J, Marcilla I, Luquin MR.
    Neurobiol Dis; 2014 Feb 15; 62():250-9. PubMed ID: 24076099
    [Abstract] [Full Text] [Related]

  • 33. Life-threatening parkinsonism induced by kava-kava.
    Meseguer E, Taboada R, Sánchez V, Mena MA, Campos V, García De Yébenes J.
    Mov Disord; 2002 Jan 15; 17(1):195-6. PubMed ID: 11835463
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Assessing nigrostriatal dysfunctions by pharmacological MRI in parkinsonian rhesus macaques.
    Zhang Z, Andersen AH, Ai Y, Loveland A, Hardy PA, Gerhardt GA, Gash DM.
    Neuroimage; 2006 Nov 01; 33(2):636-43. PubMed ID: 16949305
    [Abstract] [Full Text] [Related]

  • 38. The relationship between cerebral vascular disease and parkinsonism: The VADO study.
    Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP.
    Parkinsonism Relat Disord; 2012 Jul 01; 18(6):775-80. PubMed ID: 22531611
    [Abstract] [Full Text] [Related]

  • 39. Parkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
    Davis LE, Adair JC.
    Mov Disord; 1999 May 01; 14(3):520-2. PubMed ID: 10348484
    [No Abstract] [Full Text] [Related]

  • 40. Levodopa-responsive parkinsonism after aneurysmal subarachnoid hemorrhage.
    Fields JD, Cetas JS.
    Neurocrit Care; 2010 Oct 01; 13(2):235-8. PubMed ID: 20589451
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.